期刊文献+

外科严重脓毒症早期目标指导治疗应用价值研究 被引量:1

Value of early goal-directed therapy for treatment of surgical patients with severe sepsis
原文传递
导出
摘要 目的探讨早期目标指导治疗(EGDT)治疗外科严重脓毒症临床价值。方法将2004年8月至2007年6月收治于浙江省7家三甲医院ICU的177例外科严重脓毒症病人随机分为常规组(n=90)和EGDT组(n=87)。前者以中心静脉压(CVP)、平均动脉压(MAP)或收缩压(SBP)、尿量(UO)变化指导液体复苏,后者在此基础上增加中心静脉血氧饱和度(ScvO2)为观测指标进行复苏;入选后,对病人行输液、输血和强心等治疗,6h内达标;比较两组病人28d存活率(主要终点)、ICU住院时间、机械通气时间、抗生素使用时间、合并新感染情况和临床评分(次要终点)的差异。结果EGDT组28d存活率较常规组增高约18%(79.3%vs61.1%,P=0.023),EGDT明显改善APACHEII评分(21.7±5.9vs15.4±4.3,P=0.008)和MODS评分(8.4±3.3vs5.1±2.9,P=0.017),EGDT对其他次级终点均无显著影响(均P>0.05)。结论EGDT可以显著改善外科脓毒症病人28d存活率和临床评分,对病人预后有益。 Objective To investigate the effect of early goal-directed therapy (EGDT) on surgical patient with severe sepsis. Methods One hundred and seventy-seven surgical patients with severe sepsis admitted between August 2004 and June 2007 at 7 hospitals of Grade III Level A in Zhejiang Province were randomized to conventional treatment group (n=90) and EGDT group (n=87), the former was underwent fluid resuscitation goaled by central venous pressure (CVP), mean artery blood pressure (MBP) or systolic blood pressure (SBP) and urinary output, and the latter was guiding by CVP, MBP or SBP and UO plus central venous oxygen saturation (ScvO2); The patients were achieved the goals by treating with fluid, transfusions and cardiac stimulants in a period of 6 hours after enrollment. The difference of 28-day survival (primary endpoint), the length of stay in ICU, mechanical ventilation time, antibiotics utilization time, complication of newly infection and clinical scores (secondary endpoints) between the 2 groups was compared. Results In comparison with conventional group, the 28-day survival of EGDT group was increased by 18% (79.3% vs 61.1%, P= 0.023), the APACHE II score and MODS score were significantly improved after 6h of EGDT fluid resuscitation (APACHE Ⅱ: 21.7±5.9 vs 15.4±4.3, P=0.008; MODS: 8.4±3.3 vs 5.1 ±2.9, P=0.017), there is no difference in other parameters for secondary endpoint (all P〉0.05). Conclusion EGDT improved 28-day survival and clinical scores and had beneficial effects on outcomes in surgical patients with severe sepsis.
机构地区 浙江医院ICU
出处 《中国实用外科杂志》 CSCD 北大核心 2009年第12期1000-1002,共3页 Chinese Journal of Practical Surgery
基金 浙江省医药卫生重点科研项目(2004ZD002) 浙江省卫生高层次创新人才基金 浙江省医药卫生科技计划项目(2006A012)
关键词 脓毒症 液体复苏 sepsis fluid resuscitation
  • 相关文献

参考文献8

  • 1Rivers E, Nguyen B, Havstad S. et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock [J]. N Engl J Med,2001 345(19):1368-1377. 被引量:1
  • 2Yan J, Cai G. A multicentre study on early goal-directed therapy of severe sepsis and septic shock patients in the ICU: collaborative study group on early goal-directed therapy in Zhejiang Province, China [J]. Crit Care,2008, 12(suppl 2):417. 被引量:1
  • 3Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Chest,1992, 101(6):1644-1655. 被引量:1
  • 4Dellinger RP, Carlet JM, Masnr H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock [J]. Crit Care Med, 2004,32(3):858-873. 被引量:1
  • 5Trzeciak S, Dellinger P, Abate NL, el al. Translating research to clinical practice [ J ]. Chest, 2006,129(2):225-232. 被引量:1
  • 6Reuben AD, Appelboam AV, Higginson L, el al. Early goal-directed therapy: a UK perspective [J]. Emerg Med J, 2006, 23 (11): 828-832. 被引量:1
  • 7颜默磊,严静,蔡国龙,吴亮,张召才,龚仕金,虞意华,戴海文.早期目标性治疗对脓毒症患者血浆C反应蛋白及前降钙素水平的影响[J].中华急诊医学杂志,2009,18(1):79-81. 被引量:9
  • 8Huang DT, Clermont G, Dremsizov TT, et al. Implementation of early goal-directed therapy for severe sepsis and septic shock: a decision analysis [J]. Crit Care Med, 2007,35(9): 2090-2100. 被引量:1

二级参考文献11

  • 1Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis[J]. N Eng J Med, 2003, 348(2) : 138-150. 被引量:1
  • 2Povoa P, Mmeida E, Moreira P, et al. C-reactive protein as an indicator of sepsis[J]. Intensive Care Med, 1998, 24(10) : 1052-1056. 被引量:1
  • 3Castelli GP, Pognani C, Meisner M. et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction[J]. Crit Care,2004, 8(4) :234-242. 被引量:1
  • 4Castelli GP, Pognani C, Cita M, et al. Proealeitonin, C-reactive protein, white blood cells and SOFA score in ICU:diagnosis and monitoring of sepsis[J]. Minerva Anestesiol,2006, 72(1/2) :69-80. 被引量:1
  • 5Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345(19) : 1368-1377. 被引量:1
  • 6Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference[ J ]. Crit Care Med, 2003, 31(4) : 1250-1256. 被引量:1
  • 7American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [ J ]. Crit Care Med, 1992, 20(6) :864-874. 被引量:1
  • 8Black S, Kushner I, Samols D. C-reactive Protein[J]. J Biol Chem. 2004, 279(47): 487-490. 被引量:1
  • 9Reny JL, Vuagnat A, Ract C, et al. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables[J]. Crit Care Med, 2002,30 (3) : 529-535. 被引量:1
  • 10Hoffmann JN, Vollmar B, Laschke MW, et al. Hydroxyethyt starch (130 ku), but not crystalloid volume support, improves mierocirculation during. nonnotensive endotoxemia[J], Anesthesiology, 2002, 97(2): 460-470. 被引量:1

共引文献8

同被引文献18

  • 1Trethon A, Prinz G,Varga A, et al. Characteristics of nosocomialbloodstream infections at a Hungarian cardiac surgery centre[j].Acta Microbiol Immunol Hung, 2012, 59(2): 271-283. 被引量:1
  • 2Marra AR,Camargo LF,Pignatari AC, et al. Nosocomial blood-stream infections in Brazilian hospitals: analysis of 2,563 casesfrom a prospective nationwide surveillance study [j]. J Clin Mi-crobiol, 2011,49(5): 1866-1871. 被引量:1
  • 3Kumar A,Ellis P,Arabi Y, et al. Initiation of inappropriate anti-microbial therapy results in a fivefold reduction of survival in hu-man septic shock[j]. Chest, 2009, 136(5): 1237-1248. 被引量:1
  • 4Ammerlaan HS, Harbarth S, Buiting AG, et al. Secular trends innosocomial bloodstream infections: antibiotic-resistant bacteriaincrease the total burden of infection[j]. Clin Infect Dis,2013, 56(6): 798-805. 被引量:1
  • 5Ngo JT, Parkins MD, Gregson DB, et al. Population-based as-sessment of the incidence, risk factors, and outcomes of anaero-bic bloodstream infections [j]. Infection, 2013, 41(1): 41—48. 被引量:1
  • 6Shinagawa N,Osanai H,Hirata K, et al. Bacteria isolated fromsurgical infections and its susceptibilities to antimicrobialagents-special references to bacteria isolated between April2009 and March 2010 [J]. Jpn J Antibiot, 2011, 64(3):125-169. 被引量:1
  • 7Zhanel GG,DeCorby M,Adam H, et al. Prevalence of antimicro-bial-resistant pathogens in Canadian hospitals: results of theCanadian Ward Surveillance Study (CANWARD 2008)[j]. An-timicrob Agents Chemother, 2010,54(11): 4684-4693. 被引量:1
  • 8Ecker DJ,Sampath R,Li H, et al. New technology for rapid mo-lecular diagnosis of bloodstream infections [j]. Expert Rev MolDiagn,2010, 10(4): 399-415. 被引量:1
  • 9Lee A, Mirrett S, Reller LB, et al. Detection of bloodstream in-fections in adults: how many blood cultures are needed. [J]. JClin Microbiol, 2007,45 (11): 3546-3548. 被引量:1
  • 10薛峰,吕媛.Mohnarin 2009年度报告:血标本来源的细菌耐药监测[J].中国临床药理学杂志,2011,27(5):352-356. 被引量:20

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部